Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery
Open Access
- 15 February 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 652
Abstract
Lung cancer is one of the deadliest pulmonary diseases in the world. Although docetaxel (DTX) has exhibited superior efficacy in lung cancer treatment, it has demonstrated numerous adverse effects and poor bioavailability. The natural product extract, curcumin (CCM), has reportedly reduced toxicity and synergistically improved DTX bioavailability. Nonetheless, the hydrophobic nature of DTX and CCM limits their clinical use. Nanoemulsion pulmonary delivery of DTX and CCM has demonstrated potential as a drug carrier to alleviate these drawbacks. The controlled preparation of inhalable DTX- and CCM-loaded nanoemulsions within the 100 to 200 nm range was explored in this study. A response surface methodology (RSM) based on a central composite design (CCD) was utilized to fabricate the desired size of the nanoemulsion under optimized conditions. Different process parameters were employed to control the size of the nanoemulsions procured through a high-energy emulsification technique. The size of the resultant nanoemulsions decreased with increasing energy input. The actual response according to the targeted sizes for DTX- and CCM-loaded nanoemulsion models exhibited excellent agreement with the predicted value at below 5% residual standard error under optimized conditions. The nanoemulsion of 100 nm particle size demonstrated better membrane permeability than their larger counterparts. Moreover, the formulations documented favorable physicochemical and aerodynamic pulmonary delivery properties and reduced toxicity in human lung fibroblast (MRC-5) cells. Hence, this tunable size of nanoemulsions could be a suitable alternative drug delivery for pulmonary diseases with increased local lung concentration.Keywords
Funding Information
- Ministry of Higher Education, Malaysia (RU029-2014/5526306, NMRR-21-1103-60199 (21-058))
- National Institute of Health, Ministry of Health Malaysia (RU029-2014/5526306, NMRR-21-1103-60199 (21-058))
This publication has 63 references indexed in Scilit:
- Development and Characterization of Nanostructured Mists with Potential for Actively Targeting Poorly Water-Soluble Compounds into the LungsPharmaceutical Research, 2013
- Formulation Optimization of a Palm-Based Nanoemulsion System Containing LevodopaInternational Journal of Molecular Sciences, 2012
- Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulizationInternational Journal of Pharmaceutics, 2012
- Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica NanoconjugatesACS Nano, 2012
- Nanocarrier for the enhanced bioavailability of a cardiovascular agent: In vitro, pharmacodynamic, pharmacokinetic and stability assessmentInternational Journal of Pharmaceutics, 2011
- Evaluation of a Nanoemulsion-Based Formulation for Respiratory Delivery of Budesonide by NebulizersAAPS PharmSciTech, 2010
- Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studiesBritish Journal of Nutrition, 2010
- Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsionsColloids and Surfaces B: Biointerfaces, 2010
- Newly synthesized palm esters for cosmetics industryIndustrial Crops and Products, 2009
- Dynamic Light Scattering Studies on Ostwald Ripening and Composition Ripening of Oil Droplets in Oil-in-Water Emulsion SystemsJournal of Oleo Science, 2004